Healthcare

September 26, 2016

1

Herbalife Nutrition and Special Olympics Announce $1 Million Fitness Collaboration

Herbalife (NYSE: HLF), a global nutrition company, today announced a $1 million collaboration with Special Olympics to support the organization’s fitness programming around the world, focusing on increasing physical activity and improving nutrition and hydration.


Leveraging Herbalife Nutrition’s global team of more than 300 staff scientists and 36 Ph.Ds. specializing"...

Continue Reading >

September 25, 2016

2

Cigna Foundation Workplace Wellness Summit Set for Oct. 11 in Dubai; Leading Dubai Employers to Discuss Health, Well-being of Workforce

Leading multi-national employers in Dubai will discuss the health and well-being of the workforce at the Cigna Foundation Workplace Wellness Summit taking place Oct. 11 from 8 a.m. to 1 p.m. at the Jumeirah Emirates Towers Hotel, Sheikh Zayed Road, Dubai, United Arab Emirates (UAE). Employers, NGOs, academicians, medical professionals and others with an interest in workforce health and well-being are invited. Seated is limited, and there is no registration fee.

The"...

Continue Reading >

September 21, 2016

3

OT Supplies SESAM-Vitale in France With More Than 7 Million Health Cards a Year

Oberthur Technologies (OT), a leading global provider of embedded security software products and services, today announced that it is working in close collaboration with the SESAM-Vitale economic interest group (EIG) on two key contracts for the French health system. Starting end of 2015, OT has a three-year exclusive contract to supply 3.5 million Cartes Vitale national health cards and 4 million European Health Insurance Cards.


SESAM-Vitale"...

Continue Reading >

September 21, 2016

4

Acelity Announces Early Tender Results for the Exchange Offer and Successful Completion of the Consent Solicitation with Respect to Senior Notes Due 2019

Acelity L.P. Inc. (“Acelity”), a global advanced wound care and regenerative medicine company, today announced the results, as of 5:00 p.m., New York City time, on September 19, 2016 (the “Early Tender and Consent Date”), of (A) the private offer to Eligible Holders (as defined below) (the “Exchange Offer”) by its wholly-owned subsidiaries, Kinetic Concepts, Inc. (“KCI”) and KCI USA, Inc. (together with KCI, the “Issuers”), to exchange a portion of their 12.5% Senior"...

Continue Reading >

September 21, 2016

5

SAB Biotherapeutics' Immunotherapy Proposal among Top Platform Technology Solutions in WHO Report

SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical development company, announced today that its DiversitAb human antibody production platform, leveraging transchromosomic cattle (Tc Bovine™), was identified as of one of the six most meritorious proposals emerging from the World Health Organization (WHO) public consultation on platform technologies for priority infectious diseases"......

Continue Reading >

September 20, 2016

6

Draft bill on health to be examined in upcoming Council of Ministers

BATNA (Algeria)- The draft bill on health will be examined in the works of the upcoming council of minister said Sunday, in Batna, the minister of Health, Population and Hospital Reform Abdelmalek Boudiaf.

“It will be the largest dissemination of health reforms in Algeria because it will decide on many of the sector’s issues so far,” said the minister on the sidelines of the opening ceremony of the new school year at the National Institute"...

Continue Reading >

September 20, 2016

7

One-Year Results in Japanese Clinical Study Affirms the GORE® VIABAHN® Endoprosthesis as a Device-of-Choice for Treating Complex SFA Disease

W. L. Gore & Associates, Inc. (Gore) today announced positive results from a prospective, multicenter Investigational Device Exemption (IDE) Clinical Study of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface* in Japan. The device demonstrated excellent outcomes in treating long, complex lesions in the superficial femoral artery (SFA), achieving 88 percent primary patency at 12 months. The findings were presented during a Gore MEDICAL MASTERY Series event hosted in conjunction with the Vascular"......

Continue Reading >

September 20, 2016

8

New survey reveals 9 out of 10 patients with IPF were happy with how their doctor told them about their IPF diagnosis

  • However, need for additional information to help patients at IPF diagnosis identified
  • Survey also revealed that physicians’ understanding of their patients’ priorities were aligned with patients' actual priorities at diagnosis

A diagnosis of IPF is news that few patients want to hear from their physician, but the reality is that approximately 3 million people worldwide are living with idiopathic pulmonary"...

Continue Reading >

September 20, 2016

9

Takeda and Zydus Cadila partner to address the global threat of Chikungunya

Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) and Zydus Cadila today announced a partnership to tackle chikungunya, an emerging infectious disease in Africa, Asia and the Indian subcontinent. In recent decades mosquito vectors of chikungunya have spread to Europe and the Americas.i According to the Centers for Disease Control and Prevention (CDC) in the USA, there is currently no vaccine to prevent or medicine to treat chikungunya virus infectionii. The chikungunya virus is most often spread to people by Aedes aegypti"......

Continue Reading >

September 19, 2016

10

First Implant Completed in Pivotal Study of GORE® TAG® Thoracic Branch Endoprosthesis

W. L. Gore & Associates, Inc. (Gore) today announced the first implant of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE) in the pivotal study. The patient was enrolled by Himanshu Patel, MD, section head of adult cardiac surgery at the University of Michigan Frankel Cardiovascular Center and co-national principal investigator.


The objective of the study is"...

Continue Reading >
 

Forex Market Video